190 related articles for article (PubMed ID: 34193285)
21. Diffuse midline gliomas, H3 K27M-mutant are associated with less peritumoral edema and contrast enhancement in comparison to glioblastomas, H3 K27M-wildtype of midline structures.
Banan R; Akbarian A; Samii M; Samii A; Bertalanffy H; Lehmann U; Hartmann C; Brüning R
PLoS One; 2021; 16(8):e0249647. PubMed ID: 34347774
[TBL] [Abstract][Full Text] [Related]
22. Spinal Cord Astrocytoma with Isocitrate Dehydrogenase 1 Gene Mutation.
Takai K; Tanaka S; Sota T; Mukasa A; Komori T; Taniguchi M
World Neurosurg; 2017 Dec; 108():991.e13-991.e16. PubMed ID: 28866063
[TBL] [Abstract][Full Text] [Related]
23. Spinal cord high-grade infiltrating gliomas in adults: clinico-pathological and molecular evaluation.
Alvi MA; Ida CM; Paolini MA; Kerezoudis P; Meyer J; Barr Fritcher EG; Goncalves S; Meyer FB; Bydon M; Raghunathan A
Mod Pathol; 2019 Sep; 32(9):1236-1243. PubMed ID: 31028365
[TBL] [Abstract][Full Text] [Related]
24. Impact of H3.3 K27M Mutation on Prognosis and Survival of Grade IV Spinal Cord Glioma on the Basis of New 2016 World Health Organization Classification of the Central Nervous System.
Yi S; Choi S; Shin DA; Kim DS; Choi J; Ha Y; Kim KN; Suh CO; Chang JH; Kim SH; Yoon DH
Neurosurgery; 2019 May; 84(5):1072-1081. PubMed ID: 29718432
[TBL] [Abstract][Full Text] [Related]
25. ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma.
Reuss DE; Sahm F; Schrimpf D; Wiestler B; Capper D; Koelsche C; Schweizer L; Korshunov A; Jones DT; Hovestadt V; Mittelbronn M; Schittenhelm J; Herold-Mende C; Unterberg A; Platten M; Weller M; Wick W; Pfister SM; von Deimling A
Acta Neuropathol; 2015 Jan; 129(1):133-46. PubMed ID: 25427834
[TBL] [Abstract][Full Text] [Related]
26. Brainstem pilocytic astrocytoma with H3 K27M mutation: case report.
Morita S; Nitta M; Muragaki Y; Komori T; Masui K; Maruyama T; Ichimura K; Nakano Y; Sawada T; Koriyama S; Tsuzuki S; Yasuda T; Hashimoto K; Niwa A; Kawamata T
J Neurosurg; 2018 Sep; 129(3):593-597. PubMed ID: 28960151
[TBL] [Abstract][Full Text] [Related]
27. The histomolecular criteria established for adult anaplastic pilocytic astrocytoma are not applicable to the pediatric population.
Gareton A; Tauziède-Espariat A; Dangouloff-Ros V; Roux A; Saffroy R; Castel D; Kergrohen T; Fina F; Figarella-Branger D; Pagès M; Bourdeaut F; Doz F; Puget S; Dufour C; Lechapt E; Chrétien F; Grill J; Varlet P
Acta Neuropathol; 2020 Feb; 139(2):287-303. PubMed ID: 31677015
[TBL] [Abstract][Full Text] [Related]
28. IDH mutant lower grade (WHO Grades II/III) astrocytomas can be stratified for risk by CDKN2A, CDK4 and PDGFRA copy number alterations.
Yang RR; Shi ZF; Zhang ZY; Chan AK; Aibaidula A; Wang WW; Kwan JSH; Poon WS; Chen H; Li WC; Chung NY; Punchhi G; Chu WC; Chan IS; Liu XZ; Mao Y; Li KK; Ng HK
Brain Pathol; 2020 May; 30(3):541-553. PubMed ID: 31733156
[TBL] [Abstract][Full Text] [Related]
29. The utility of DNA methylation analysis in elderly patients with pilocytic astrocytoma morphology.
Suruga Y; Satomi K; Otani Y; Fujii K; Ishida J; Uneda A; Tsuboi N; Makino K; Hirano S; Kemmotsu N; Imoto R; Mizuta R; Tomita Y; Yasuhara T; Washio K; Yanai H; Matsushita Y; Hibiya Y; Yoshida A; Capper D; Ichimura K; Date I
J Neurooncol; 2022 Oct; 160(1):179-189. PubMed ID: 36107362
[TBL] [Abstract][Full Text] [Related]
30. Pediatric spinal pilocytic astrocytomas form a distinct epigenetic subclass from pilocytic astrocytomas of other locations and diffuse leptomeningeal glioneuronal tumours.
Métais A; Bouchoucha Y; Kergrohen T; Dangouloff-Ros V; Maynadier X; Ajlil Y; Carton M; Yacoub W; Saffroy R; Figarella-Branger D; Uro-Coste E; Sevely A; Larrieu-Ciron D; Faisant M; Machet MC; Wahler E; Roux A; Benichi S; Beccaria K; Blauwblomme T; Boddaert N; Chrétien F; Doz F; Dufour C; Grill J; Debily MA; Varlet P; Tauziède-Espariat A
Acta Neuropathol; 2023 Jan; 145(1):83-95. PubMed ID: 36264505
[TBL] [Abstract][Full Text] [Related]
31. Clinicoradiological characteristics of primary spinal cord H3 K27M-mutant diffuse midline glioma.
Cheng L; Wang L; Yao Q; Ma L; Duan W; Guan J; Zhang C; Wang K; Liu Z; Wang X; Wang Z; Wu H; Chen Z; Jian F
J Neurosurg Spine; 2022 Feb; 36(2):303-314. PubMed ID: 34560639
[TBL] [Abstract][Full Text] [Related]
32. Prognosis and treatment of spinal cord astrocytoma.
Minehan KJ; Brown PD; Scheithauer BW; Krauss WE; Wright MP
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):727-33. PubMed ID: 18687533
[TBL] [Abstract][Full Text] [Related]
33. Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosis.
Suwala AK; Stichel D; Schrimpf D; Kloor M; Wefers AK; Reinhardt A; Maas SLN; Kratz CP; Schweizer L; Hasselblatt M; Snuderl M; Abedalthagafi MSJ; Abdullaev Z; Monoranu CM; Bergmann M; Pekrun A; Freyschlag C; Aronica E; Kramm CM; Hinz F; Sievers P; Korshunov A; Kool M; Pfister SM; Sturm D; Jones DTW; Wick W; Unterberg A; Hartmann C; Dodgshun A; Tabori U; Wesseling P; Sahm F; von Deimling A; Reuss DE
Acta Neuropathol; 2021 Jan; 141(1):85-100. PubMed ID: 33216206
[TBL] [Abstract][Full Text] [Related]
34. Pediatric spinal cord diffuse midline glioma, H3 K27-altered with intracranial and spinal leptomeningeal spread: A case report.
Serrallach BL; Tran BH; Bauer DF; Mohila CA; Adesina AM; McGovern SL; Lindsay HB; Huisman TA
Neuroradiol J; 2022 Oct; 35(5):634-639. PubMed ID: 34989626
[TBL] [Abstract][Full Text] [Related]
35. Association of molecular alterations, including BRAF, with biology and outcome in pilocytic astrocytomas.
Horbinski C; Hamilton RL; Nikiforov Y; Pollack IF
Acta Neuropathol; 2010 May; 119(5):641-9. PubMed ID: 20044755
[TBL] [Abstract][Full Text] [Related]
36. A tailored next-generation sequencing panel identified distinct subtypes of wildtype IDH and TERT promoter glioblastomas.
Higa N; Akahane T; Yokoyama S; Yonezawa H; Uchida H; Takajo T; Kirishima M; Hamada T; Matsuo K; Fujio S; Hanada T; Hosoyama H; Yonenaga M; Sakamoto A; Hiraki T; Tanimoto A; Yoshimoto K
Cancer Sci; 2020 Oct; 111(10):3902-3911. PubMed ID: 32748499
[TBL] [Abstract][Full Text] [Related]
37. The role of neuropathology in the management of newly diagnosed glioblastoma: a systematic review and evidence-based clinical practice guideline.
Velázquez Vega JE; Brat DJ; Ryken TC; Olson JJ
J Neurooncol; 2020 Nov; 150(2):143-164. PubMed ID: 33215342
[TBL] [Abstract][Full Text] [Related]
38. Comprehensive analysis of diverse low-grade neuroepithelial tumors with FGFR1 alterations reveals a distinct molecular signature of rosette-forming glioneuronal tumor.
Lucas CG; Gupta R; Doo P; Lee JC; Cadwell CR; Ramani B; Hofmann JW; Sloan EA; Kleinschmidt-DeMasters BK; Lee HS; Wood MD; Grafe M; Born D; Vogel H; Salamat S; Puccetti D; Scharnhorst D; Samuel D; Cooney T; Cham E; Jin LW; Khatib Z; Maher O; Chamyan G; Brathwaite C; Bannykh S; Mueller S; Kline CN; Banerjee A; Reddy A; Taylor JW; Clarke JL; Oberheim Bush NA; Butowski N; Gupta N; Auguste KI; Sun PP; Roland JL; Raffel C; Aghi MK; Theodosopoulos P; Chang E; Hervey-Jumper S; Phillips JJ; Pekmezci M; Bollen AW; Tihan T; Chang S; Berger MS; Perry A; Solomon DA
Acta Neuropathol Commun; 2020 Aug; 8(1):151. PubMed ID: 32859279
[TBL] [Abstract][Full Text] [Related]
39. A case report of adult cerebellar high-grade glioma with H3.1 K27M mutation: a rare example of an H3 K27M mutant cerebellar tumor.
Funata N; Nobusawa S; Nakata S; Yamazaki T; Takabagake K; Koike T; Maegawa T; Yamada R; Shinoura N; Mine Y
Brain Tumor Pathol; 2018 Jan; 35(1):29-35. PubMed ID: 29264735
[TBL] [Abstract][Full Text] [Related]
40. Diffuse astrocytic glioma, IDH-Wildtype, with molecular features of glioblastoma, WHO grade IV: A single-institution case series and review.
Lee D; Riestenberg RA; Haskell-Mendoza A; Bloch O
J Neurooncol; 2021 Mar; 152(1):89-98. PubMed ID: 33389563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
